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ABSTRACT Human fibrinogen cDNA probes for the a-,
3-, and y-polypeptide chains have been used to isolate the cor-
responding genes from human genomic libraries. There is a
single copy of each gene. Restriction endonuclease analysis of
isolated genomic clones and human genomic DNA indicates
that the human a-, 3-, and -fibrinogen genes are closely
linked in a 50-kilobase region of a single human chromosome:
the a-gene in the middle flanked by the (3-gene on one side and
the -gene on the other. The a- and 'ychain genes are oriented
in tandem and transcribed toward the (-chain gene. The (3
chain gene is transcribed from the opposite DNA strand to-
ward the y- and a-chain genes. The three genes have been
localized to the distal third of the long arm of chromosome 4,
bands q23-q32, by in situ hybridization with fibrinogen
cDNAs and by examination of DNA from multiple rodent-hu-
man somatic cell hybrids. Alternative explanations for the
present arrangement of the three fibrinogen genes involve ei-
ther a three-step mechanism with inversion of the a/-region
or a two-step mechanism involving remote transposition and
inversion. The second more simple mechanism has a precedent
in the origin of repeated regions of the fibrinogen and immu-
noglobulin genes.
The major clotting factor, fibrinogen, is a complex protein of
340,000 Mr composed of paired groups of three nonidentical
polypeptides designated the a-, /3, and y-chains (1, 2). Sig-
nificant homologies among amino acid (1, 2) and cDNA (3-
6) sequences for the human a-, /3, and y-fibrinogen chains
indicate that the genes encoding these polypeptides have
arisen by duplication and subsequent evolutionary diver-
gence of an ancestral gene. Data from a number of multigene
families, including a- and f3globins (7), immunoglobulin
heavy (8) and light (9-11) chains, cardiac myosin heavy
chains (12), a-interferons (13), histones (14), and a variety of
insect genes (15-18), illustrate that such duplications are of-
ten local, leading to clustering of related gdnes in a small
region of a single chromosome. In fact, the a- and -fibrino-
gen genes have been shown to be molecularly linked in the
rat (19). In these studies we have used human fibrinogen a-,
/-, and -chain cDNA probes to isolate each gene in a single
copy from human genomic libraries and show that the genes
are closely linked in a small region on the long arm of chro-
mosome 4.
MATERIALS AND METHODS
Materials. Partial Hae III-Alu I and EcoRI human geno-
mic libraries constructed in the bacteriophage vector Charon
4A were kindly provided by Terry Robbins (National Cancer
Institute), Philip Leder (Harvard University), and Edward J.
Benz, Jr. (Yale University). Cloned genomic probes for hu-
man a-fetoprotein were graciously provided by Shirley
Tilghman and Rob Krumlauf (Fox Chase Institute for Cancer
Research). Human fibrinogen cDNAs have been described
(3).
Hybrid human-mouse and human-hamster cell lines were
generated by fusing human fibroblasts with rodent hypoxan-
thine phosphoribosyltransferase-negative or thymidine ki-
nase-negative fibroblasts as described (20, 21); description
of each group of hybrid cell lines used is given in the table or
figure legends. Restriction endonucleases were purchased
from Bethesda Research Laboratories and New England
Biolabs; DNase I and DNA polymerase were from Boeh-
ringer Mannheim. Unlabeled deoxynucleotide triphosphates
were purchased from P-L Biochemicals; deoxynucleotide
[a-32P] triphosphates was purchased from Amersham.
Genontic Library Screening and Mapping. The human ge-
nomic libraries were screened according to Benton and Da-
vis (22) by using 32P-labeled, nick-translated (>108 d /g)
cDNAs for the a-, p-, and y-chains of human fibrinogen (3).
DNA was prepared from isolated bacteriophage clones hy-
bridizing with.these probes according to Maniatis et al. (23).
DNAs were digested with restriction endonucleases accord-
ing to the supplier's instructions and analyzed on agarose
and polyacrylamide gels.
Chromosomal Assignment of Fibrinogen Genes. Cell pellets
from rodent-human somatic cell hybrids were prepared
simultaneously for DNA isolation (24) and isoenzyme analy-
ses. Human fibrinogen cDNAs were hybridized to nitrocel-
lulose filters containing EcoRI-digested, size-fractionated
cellular DNAs (25). The human chromosomes present in
each hybrid cell line were determined from starch gel elec-
trophoretic analyses-(26, 27) of the isoenzyme markers that
have been assigned previously to each of the human chromo-
somes (28).
For in situ hybridization studies, human metaphase and
prometaphase chromosomes were prepared from methotrex-
ate-synchronized peripheral blood cultures (29). All' slide
preparations were aged 1 week before use. Human fibrino-
gen cDNAs were nick-translated according to Lai et al. (30)
to a specific' activity of 107 cpm/gg using [3H]dATP (60
Ci/mmol; 1 Ci = 37 GBq) and [3H]dTTP (97 Ci/mmol). In
situ hybridizations were performed according to Harper and
Saunders (31) at 370C for 12-14 hr with probe concentrations
of 0.25-1.0 ng/ml in 0.3 M NaCl/0.03 M sodium citrate),
50% formamide with 10% dextran sulfate, and a 500-fold ex-
cess of carrier DNA. The slides were rinsed three times in
50% formamide/0.3 M NaCl/0.03 M sodium citrate and five
Abbreviation: kb, kilobase(s).
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FIG. 1. Human genomic DNA probed with fibrinogen cDNAs.
Human leukocyte DNA from two individuals was digested with re-
striction endonucleases HindIll (lanes 1, 3, 5, 7, 9, 11) or EcoRI
(lanes 2, 4, 6, 8, 10, 12). Ten micrograms was run per lane on a 0.7%
agarose gel, transferred to nitrocellulose, and hybridized to human
y- (lanes 1-4), ,8- (lanes 5-8), and a- (lanes 9-12) fibrinogen cDNAs.
DNA from one is in lanes 1, 2, 5, 6, 9, and 10. DNA from a second
individual is in lanes 3, 4, 7, 8, 11, and 12. Molecular sizes are given
at the side. The cDNAs were 2275, 855, and. 736 base pairs for the
a-, /3-, and y-chains, respectively.
times in 0.3 M NaCl/0.03 M sodium citrate at 390C, dehy-
drated, and coated with Kodak NTB2 emulsion (diluted 1:1
with water). After 5-30 days at 40C in light-tight boxes with
Drierite, the slides were developed and chromosomes G-
banded as described by Chandler and Yunis (32). Grains
were scored only if they touched at least one chromatid.
RESULTS
Isolation of Single-Copy Fibrinogen Genes. Three human
genomic libraries were screened initially with human fibrino-
gen a-, 13, and y-cDNAs. Of -2 x 106 plaques screened 5,
11, and 24 hybridized with the a-, 1-, and y-cDNAs, respec-
tively. Several pieces of evidence indicate that each fibrino-
gen gene exists in a single copy in the human genome. A
variety of restriction endonucleases produced a simple hy-
bridization pattern often with a single band on Southern
transfers of genomic DNA probed with the fibrinogen
cDNAs (Fig. 1). Moreover, the restriction endonuclease
maps of each genomic isolate that hybridized with a single
cDNA could be overlapped with all others hybridizing with
the probe (see Fig. 2). In the absence of a very recent gene
duplication, these data indicate that each isolate comes from
a single genomic locus. Finally, each restriction fragment
from leukocyte DNA that hybridized to an individual fibrin-
ogen cDNA on Southern blots could be accounted for by an
identically sized restriction fragment from the genomic
clones that also hybridized with that cDNA (Figs. 1 and 2).
Molecular Linkage of Human a-, (3-, and yFibrinogen
Genes. Restriction endonuclease maps of the genomic iso-
lates for individual fibrinogen genes could be overlapped, in-
dicating that the three single-copy genes were directly adja-
cent in vivo (Fig. 2). The a-chain gene is located in the center
of the cluster with the y-chain gene -10 kilobases (kb) away
to one side and the /3-chain gene =13 kb to the other. There
was 3 kb of overlap between isolates y3 and al, as judged by
identically placed sites for four restriction enzymes (all en-
zymes not indicated in Fig. 2). In addition, a nonrepetitive
450-base-pair HindIII fragment isolated from the most distal
portion of clone y3 in the predicted region of overlap with
clone al hybridized strongly with the expected region in al.
A much larger overlap of roughly 12 kb was seen between
clones a2 and /31. When 4.8- and 4.3-kb HindIII fragments
from these regions of apparent identity were subcloned inde-
pendently from a2 and (81 and compared with the five base
recognition enzymes Ava II and Hinfl, an identical array of
fragments was seen.
Transcriptional Orientation of the Linked Fibrinogen
Genes. The transcriptional orientation of each human fibrin-
ogen gene was determined by comparing hybridization pat-
terns of the genomic isolates with full-length and 3' frag-
ments from the a- and A-cDNAs and by nucleotide sequenc-
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FIG. 2. Organization of the human fibrinogen gene locus. Restriction endonuclease maps are shown of representative overlapping genomic
isolates that hybridized with human a-, /-, and y-fibrinogen cDNAs (3). Restriction endonucleases: E = EcoRI, B = BamHI, T = Sst I, H =
HindIII, X = Xba I, K = Kpn I. The estimated length of each gene and exon-intron positions are depicted above each gene. These lengths were
determined for the a-chain gene based on hybridization with the nearly full-length cDNA and comparison to the rat a-gene sequence (33), for
the (-chain gene based on cDNA hybridization and the results of Chung et al. (5), and for the y-chain gene based on cDNA hybridization and
nucleotide sequence studies (34, 35).
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ing for the y- and ,-chain genes (34, 35). The y- and a-chain
genes are transcribed in the same direction toward the 3-
chain gene. In contrast, the -chain gene is transcribed in the
opposite direction toward the a- and y-chain genes (Fig. 2).
Localization of Human Fibrinogen Genes on Chromosome
4. The three human genes were mapped to chromosome 4 by
analysis of a series of human-mouse and human-hamster
somatic cell hybrid lines. Each cell line's human chromo-
somal composition was characterized by isoenzyme analy-
sis. DNA from each was digested with EcoRI and analyzed
on Southern blots with fibrinogen cDNAs using the charac-
teristic 2500-, 6000-, and 5000-base-pair bands as respective
markers for the a-, p-, and --chain genes (e.g., Fig. 1). Pre-
liminary experiments on 32 such lines showed that the three
genes segregated together (data not shown). These and sub-
sequent analyses of DNAs from 35 additional hybrid lines
using the a-cDNA probe alone showed no discordancy with
human chromosome 4 (Table 1). A typical experiment in Fig.
3 compares hybridization using the a-cDNA probe with
chromosomal composition by isoenzyme analysis; only
chromosome 4 showed a match.
In situ hybridization of fibrinogen cDNAs to human meta-
phase chromosomes further localized each of the three genes
approximately two-thirds of the way down the long arm of
chromosome 4, bands q23-q32. Fig. 4 displays the localiza-
tion of silver grains on particular human chromosomes. An
average of 1.6 silver grains was observed in the 71 meta-
phases analyzed. Grains were located on 4q in 45% of the
metaphases. Of the grains on chromosome 4, 73% were lo-
cated in bands q23-q32 for a total of 23% of all grains count-
ed. This represented an 11.3-fold increase over background
counts or normal distribution along other chromosomes.
DISCUSSION
It is clear from these studies that the genes encoding the a-,
P-, and y-chain polypeptides of human fibrinogen occur as
single copies closely linked in a roughly 50-kb region of chro-
mosome 4, bands q23-q32. The chromosomal assignment
agrees with previous reports for the -chain gene by family
studies (36) and a report by Henry et al. using cDNA clones
and somatic cell hybrids (37). The arrangement of all genes
Table 1. Segregation of human a-fibrinogen with human
chromosome 4
% discordancy
Total a-Fibrinogen Other
Series hybrids positive Chromosome 4 chromosomes
A 16 6 0 .25a
B 34 18 0 226b
C 17 10 0 .24
Human a-fibrinogen cDNA was hybridized to nitrocellulose fil-
ters containing EcoRI-digested, size-fractionated cellular DNA from
a number of hybrid cell lines. Series A represents hybrids isolated
after fusing human fibroblasts containing a reciprocal X:14 chromo-
some translocation (GM0073) with hypoxanthine phosphoribosyl-
transferase-negative Chinese hamster fibroblasts as described (21).
Series B represents subclones of one human-hamster and three
human-mouse hybrid cell lines. Series C is described in the legend
to Fig. 3. Independent segregation of a human chromosome and
human a-fibrinogen represents discordancy. Detection of hybrid-
izing bands of the size expected from genomic clones (see Fig. 1)
correlated with the presence or absence of human chromosome 4 in
all hybrids when compared to the isoenzyme profile (26, 27); the
presence of chromosome 4 was corroborated in these lines by
positive hybridization with cloned genomic probes to a-fetoprotein.
The minimal discordancy between segregation of all other human
chromosomes and a-fibrinogen is shown with the following excep-
tions: a, 13% discordancy with chromosome 17; b, single discor-
dancy (3%) with chromosome 3.
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FIG. 3. Distribution of the human fibrinogen gene and chromo-
somal composition in human-rodent hybrid cell lines. Individual hy-
brid cell lines are represented on the ordinate and specific human
chromosomes are represented on the abscissa. Solid boxes indicate
the presence of a particular human chromosome in a hybrid line and
open boxes indicate absence of the chromosome. The presence of
human a-fibrinogen (Fib.) sequences is shown by stippled boxes.
The symbols P and A indicate the presence of markers for the short
or long arm of a chromosome, respectively. Lines 16, 18-20, and 28
are human-mouse primary hybrid cell lines described previously
(20). Lines 29-52 were isolated after fusing well-characterized hu-
man fibroblasts containing a reciprocal 2:6 chromosome transloca-
tion (GM2658) with Chinese hamster fibroblasts. Lines 21-1 to 21-4
are four subclones of a human-mouse hybrid line.
encoding multichain protein in a small region of a single
chromosome is somewhat unusual in eukaryotic systems.
The genes that form such proteins are generally found on
separate chromosomes, as exemplified by globins (7), immu-
noglobulins (8-11), and thyrotropin (38).
The tight clustering of the three genes is reminiscent of
that seen in a number of eukaryotic gene families that have
arisen by duplication and divergence from an ancestral gene
(7-18). It is clear from amino acid and nucleotide sequence
homologies among the three fibrinogen genes (1-6) as well as
similarities of exon-intron domains at the 5' ends of the
genes (33) that the a-, /3-, and 'y-fibrinogen genes have
evolved in this fashion. An ancestral gene duplicated to form
the a-chain gene and a pref-,,-gene -1 billion years ago. The
pre,&-y-gene then duplicated somewhat more than 500 mil-
lion years ago to yield individual P- and y-genes (1, 33).
Given the fact that the /3- and y-chain genes are products
of a more recent duplication than the a-chain gene, several
aspects of fibrinogen gene organization are unexpected.
First, the presence of the a-gene between the more closely
related P- and y-genes rather than at one end of the cluster is
not predicted by simple duplication or unequal crossing over
at meosis. Second, the opposite transcriptional orientation
of the ,- and a-genes is again not predicted by simple dupli-
cation or unequal crossing over. Tandem orientation of each
gene in the same direction, head to tail, is the rule for most
mammalian multigene families (7-14); however, it seems
likely that other gene families with divergently oriented tran-
scriptional units will be described, given the example of fi-
brinogen and the presence of a number of divergently orient-
ed genes in prokaryotes (39) and insects (15-18).
Alternative mechanisms explaining the arrangement and
transcriptional orientation of the human fibrinogen genes are
presented in Fig. 5. The more conventional and more com-
plex model involves the three steps shown in Fig. SA. The
first two steps are gene duplications, and the third step in-
volves inversion of the a/-,regions. An alternative simpler
mechanism involving only two steps is shown in Fig. 5B and
is suggested by the presence within fibrinogen and immuno-
2346 Biochemistry: Kant et aL
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FIG. 4. Chromosomal localization of the human fibrinogen genes by in situ hybridization. Distribution of grains counted in 71 metaphases
hybridized with human fibrinogen cDNA; 23% of all grains were located in bands 4q23-4q32.
globulin genes of small duplications flanked by single-copy
inverted repeats (34). These structures appear to have arisen
about 10-20 million years ago since a similar degree of ho-
mology exists between the two arms of the inverted repeat
and between the duplicated sequence and its origin. These
previously described duplications suggest a mechanism for
the organization of the fibrinogen genes involving, first, gene
duplication to produce the a- and 3/y-precursors and, sec-
ond, duplication of the P/y-precursor accompanied by re-
mote transposition and inversion. The lack of inverted re-
peats in the published fibrinogen gene sequence (33, 34) is
easily explained since the arms of the inverted repeat evolve
under no selective pressure and hence would have disap-
peared in the 500-1000 million years since the second dupli-
cation.
Since the a-, /-, and y-chains are present in fibrinogens
spanning a wide variety of species from lampreys to pri-
mates, differences in the organization of the fibrinogen com-
plex in distantly related species will be of interest. Note that
the model presented in Fig. SA predicts the existence of spe-
A Ancestral Gene
at prefl/-
I
----
\
-
caO m
\
cies with all three genes in the same transcriptional orienta-
tion. The linkage and orientation of a- and
-y-genes in rats are
the same as in humans (19), although examination of 8-10 kb
at the 3' end of both the 1- and a-genes and 15-20 kb at the 5'
ends of both the 1- and y-genes has not yet shown linkage of
the /-gene.
The mRNAs for the three fibrinogen genes are coordinate-
ly regulated (40) at the level of transcription (unpublished
data). The close chromosomal linkage of the three fibrinogen
genes reported in this paper suggests that regional chromo-
somal influences and/or the homologous regions at the 5'
ends of each fibrinogen gene (41) could play a role in coordi-
nating the activity of these three genes. However, the oppos-
ing transcriptional orientation of the three genes proves that
the coordinate expression of the fibrinogen genes is not re-
lated to the production of a single nuclear transcript encom-
passing all three genes.
These studies were supported in part by Grant HL/GM 33942-01
from the National Institutes of Health.
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FIG. 5. Alternative mechanisms for the present arrangement of the fibrinogen genes. Note that the first mechanism postulates the existence
of species that do not have the inverted 8-chain.
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